Advertisement

Neurocritical Care

, Volume 8, Issue 2, pp 253–258 | Cite as

Perioperative Neurological Complications After Liver Transplantation are Best Predicted by Pre-transplant Hepatic Encephalopathy

  • Rajat Dhar
  • G. Bryan Young
  • Paul Marotta
Original Research

Abstract

Introduction

Liver transplant (LT) recipients are at significant risk for the development of neurological complications, such as altered mental status and seizures, in the postoperative period. Identifying accurate predictors of these events may allow optimal selection and preparation of candidates, and minimize risk after transplantation.

Methods

One hundred and one consecutive adult LT recipients were evaluated retrospectively for neurological morbidity occurring in the first 30 days postoperatively. These events were analyzed in relation to specific predictive variables including preoperative complications of liver failure, such as hepatic encephalopathy (HE).

Results

Median age was 50 years, 63% were male and hepatitis C was the most common indication for LT (n = 36). Median Child-Pugh score was 9 with 45% being Class C. Over half (n = 52) had experienced clinical HE prior to LT, while one quarter (n = 26) were encephalopathic at the time of LT. Neurological complications occurred in 31 patients in the postoperative period, with encephalopathy occurring in 28 and seizures occurring in 4; drug toxicity was responsible for neurological morbidity in 12 patients (39%). Length of hospital stay was significantly prolonged (median 19 vs. 12 days, P = 0.005) and all mortality (n = 3) occurred in those with neurological complications. There was no association between etiology of liver failure and complications; logistic regression identified active preoperative HE as the strongest predictor of postoperative morbidity (OR 10.7 95% CI 3.8–29.9).

Conclusion

Neurological events, manifesting most often as encephalopathy, occurred in almost one-third of patients after LT. Those suffering from HE at the time of LT may be more vulnerable to the metabolic stresses of surgery and the neurotoxicity of the drugs used, and were at highest risk for such complications.

Keywords

Liver transplantation Hepatic encephalopathy Complications Postoperative Seizures Drug toxicity 

References

  1. 1.
    Moore KA, Jones R, Burrows GD. Quality of life and cognitive function of liver transplant patients: a prospective study. Liver Transpl. 2000;6:633–2.PubMedCrossRefGoogle Scholar
  2. 2.
    Mazariegos GV, Molmenti EP, Kramer DJ. Early complications after orthotopic liver transplantation. Surg Clin N Am 1999;79:109–29.PubMedCrossRefGoogle Scholar
  3. 3.
    Lodi R, Tonon C, Stracciari A, et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brain of cirrhotics. Neurology 2004;62:762–6.PubMedGoogle Scholar
  4. 4.
    Weissenborn K, Bokemeyer M, Ahl B, et al. Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 2004;19:269–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Adams DH, Ponsford S, Gunson B, et al. Neurological complications following liver transplantation. Lancet 1987;1(8539):949–51.PubMedCrossRefGoogle Scholar
  6. 6.
    Guarino M, Stracciari A, Pazzaglia P, et al. Neurological complications of liver transplantation. J Neurol 1996;243:137–42.PubMedCrossRefGoogle Scholar
  7. 7.
    Lewis MB, Howdle PD. Neurological complications of liver transplantation in adults. Neurology 2003;61:1174–8.PubMedGoogle Scholar
  8. 8.
    Menegaux F, Keefe EB, Andrews BT, et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 1994;58:447–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Borhani Haghighi A, Malekhosheini SA, Bahramali E, et al. Neurological complications of first 100 orthotopic liver transplantation patients in southern Iran. Transplant Proc 2005;37:3197–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients—incidence, timing, and long-term follow-up. Clin Transplant 2000;14:1–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000;13:313–26.PubMedCrossRefGoogle Scholar
  12. 12.
    Pujol A, Graus F, Rimola A, et al. Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994;44:1226–30.PubMedGoogle Scholar
  13. 13.
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus in bleeding oesophageal varices. Br J Surg 1973;60:646–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Aggarwal S, Kang Y, Freeman JA, Fortunato Jr FL, Pinksy MR. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 1993;8:154–60.PubMedCrossRefGoogle Scholar
  15. 15.
    Vecino MC, Cantisani G, Zanotelli ML, et al. Neurological complications in liver transplantation. Transplant Proc 1999;31:3048–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Glass GA, Stankiewicz J, Mithoefer A, Freeman R, Bergethon PR. Levetiracetam for seizures after liver transplantation. Neurology 2005;64:1084–5.PubMedGoogle Scholar
  17. 17.
    Wijdicks EF, Plevak DJ, Wiesner RH, Steers JL. Causes and outcome of seizures in liver transplant recipients. Neurology 1996;47:1523–5.PubMedGoogle Scholar
  18. 18.
    Abbasoglu O, Goldstein RM, Vodapally MS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998;12:263–9.PubMedGoogle Scholar
  19. 19.
    Buis IC, Wiesner RH, Krom RA, Kremers WK, Wijdicks EF. Acute confusional state following liver transplantation for alcoholic liver disease. Neurology 2002;59:601–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000;32:1035–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Laubenberger J, Haussinger D, Bayer S, Guffler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997;112:1610–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Haussinger D, Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem Int 2005;47:64–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Mattarozzi K, Stracciari A, Vignatelli L, D’Allessandro R, Morelli MC, Guarino M. Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. Arch Neurol 2004;61:242–7.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  1. 1.Department of NeurologyWashington University School of MedicineSaint LouisUSA
  2. 2.Department of Clinical Neurological SciencesUniversity of Western OntarioLondonCanada
  3. 3.Multi-Organ Transplant UnitLondon Health Sciences CentreLondonCanada

Personalised recommendations